Catalogs >
Pie Medical Imaging >
CAAS A-Valve brochure

CAAS A-Valve brochure
1 / 1Pages

Catalog excerpts

“Evaluation and quantification of aortic regurgitation directly after valve placement in the cathlab” Caas A-valve assists the physician in the evaluation and quantification of aortic regurgitation after transcatheter valve replacement. The amount of regurgitation is quantified using the regurgitation index, LVOT-AR. The LVOT-AR is based on the contrast density in the aortic root and left ventricle. Additionally, a dynamic color map visualizes the severity and extend of the regurgitation. Objective aortic regurgitation (AR) evaluation after TAVR in the cathlab Cut-off value of 0.17, potential indicator for 1 year event rate [1] Fast and robust workflow – easy and reproducible Directly connected with any X-ray system [1] Tateishi, H. et al. (2016). Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry. EuroIntervention : journal of EuroPCR, 11(12), 1409–1418. https://doi.org/10.4244/EIJV11I12A271 Quality Assurance: Pie Medical Imaging develops, produces and sells products in accordance with international accepted standards. Caas A-Valve is FDA 510(k) cleared and CE marked. Go to www.piemedicalimaging.com or scan the QR code for more information or a free t

Open the catalog to page 1